| [1] |
Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome [J]. N Engl J Med, 2002, 346(10): 752-763.
|
| [2] |
Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) [J]. J Thromb Haemost, 2006, 4(2): 295-306.
|
| [3] |
Gómez-Puerta JA, Cervera R. Diagnosis and classification of the antiphospholipid syndrome [J]. J Autoimmun, 2014, 2-3(48-49): 20-25.
|
| [4] |
Ruiz-Irastorza G, Crowther M, Branch W, et al. Antiphospholipid syndrome [J]. Lancet, 2010, 376(9751): 1498-1509.
|
| [5] |
Pons-Estel GJ, Andreoli L, Scanzi F, et al. The antiphospholipid syndrome in patients with systemic lupus erythematosus [J]. J Autoimmun, 2017, 76: 10-20.
|
| [6] |
Hughes GR. Thrombosis, abortion, cerebral disease, and the lupus anticoagulant [J]. Br Med J (Clin Res Ed), 1983, 287(6399): 1088-1089.
|
| [7] |
McClain MT, Arbuckle MR, Heinlen LD, et al. The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus [J]. Arthritis Rheum, 2004, 50(4): 1226-1232.
|
| [8] |
Choi H, Ahn SS, Song JJ, et al. Anti-phospholipid antibody syndrome occurrence in patients with persistent anti-phospholipid antibodies [J]. Rheumatol Int, 2019, 39(8): 1359-1367.
|
| [9] |
陈惠萍，刘志红，胡伟新，等．继发性IgA肾病常见病因及其病理特征分析[J]．肾脏病与透析肾移植杂志，2007，16(3):222-228.
|
| [10] |
Mestecky J, Raska M, Julian BA, et al. IgA nephropathy: molecular mechanisms of the disease [J]. Annu Rev Pathol, 2013, 8: 217-240.
|
| [11] |
张银花．来氟米特联合糖皮质激素治疗IgA肾病蛋白尿患者的临床效果[J]．医疗装备，2019，32(8):80-81.
|